Stephanie L. Rager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stephanie L. Rager has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Melody Y. Zeng
Gale and Ira Drukier Institute for Children’s Health, Weill Cornell Medicine
4 shared publications - Julia A. Brown
Gale and Ira Drukier Institute for Children’s Health, Weill Cornell Medicine, New York, NY 10065, USA
2 shared publications Alexandria Rose Savage
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA
1 shared publication- Andrea Heras
Department of Pediatrics, Weill Cornell Medicine, New York, NY
1 shared publication - Aparna Ananthanarayanan
Gale and Ira Drukier Institute for Children’s Health, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA
1 shared publication - Aparna Ananthanarayanan
Icahn School of Medicine at Mount Sinai 1 Division of Hematology and Medical Oncology, Tisch Cancer Institute New York, New York
1 shared publication
Latest Publications
- Open Access
Increased S. epidermidis in the airway-gut microbiome of infants with bronchopulmonary dysplasia
Rationale: Bronchopulmonary dysplasia (BPD), the lung disease associated with premature birth, is a significant health problem, often with long-term respiratory consequences. Recent research has highlighted the potential role of the lung and gut microbiome in the development and progression of BPD, yet it is unclear what aspects of the microbiome may contribute to BPD susceptibility. Objectives: To comprehensively characterize the lung and gut microbiomes of preterm infants and identify shared microbial taxa that are associated with BPD development. Methods: Tracheal aspirate and stool samples were collected from 39 premature infants over the first month of life. To assess the taxonomic microbial composition of the lung and gut, samples were analyzed using shotgun metagenomic sequencing. BPD classification was determined using the National Institute of Child Health and Human Development severity-based definition at 36 weeks postmenstrual age. Measurements and Main Results: Microbial communities of the lung and gut were significantly different between infants who went on to develop BPD and those who did not, with an enrichment of skin-associated microbial genera such as Staphylococcus, Corynebacterium, and Cutibacterium in infants who developed BPD. Specifically, Staphylococcus epidermidis was enriched in premature infants who developed BPD and was the most prominent species shared between lung and gut communities. Temporal changes in gut microbial communities co-occurred with feeding practices and antibiotic exposure, suggesting an influence of external factors on microbiome composition. Conclusions: Our findings provide evidence that certain microbial colonization patterns among premature infants are closely associated with the pathogenesis and progression of BPD.
Open AccessIncreased S. epidermidis in the airway-gut microbiome of infants with bronchopulmonary dysplasia
Rationale: Bronchopulmonary dysplasia (BPD), the lung disease associated with premature birth, is a significant health problem, often with long-term respiratory consequences. Recent research has highlighted the potential role of the lung and gut microbiome in the development and progression of BPD, yet it is unclear what aspects of the microbiome may contribute to BPD susceptibility. Objectives: To comprehensively characterize the lung and gut microbiomes of preterm infants and identify shared microbial taxa that are associated with BPD development. Methods: Tracheal aspirate and stool samples were collected from 39 premature infants over the first month of life. To assess the taxonomic microbial composition of the lung and gut, samples were analyzed using shotgun metagenomic sequencing. BPD classification was determined using the National Institute of Child Health and Human Development severity-based definition at 36 weeks postmenstrual age. Measurements and Main Results: Microbial communities of the lung and gut were significantly different between infants who went on to develop BPD and those who did not, with an enrichment of skin-associated microbial genera such as Staphylococcus, Corynebacterium, and Cutibacterium in infants who developed BPD. Specifically, Staphylococcus epidermidis was enriched in premature infants who developed BPD and was the most prominent species shared between lung and gut communities. Temporal changes in gut microbial communities co-occurred with feeding practices and antibiotic exposure, suggesting an influence of external factors on microbiome composition. Conclusions: Our findings provide evidence that certain microbial colonization patterns among premature infants are closely associated with the pathogenesis and progression of BPD.
- Open Access
- 29 June 2025
- Published by Wiley in JPGN Reports
- Vol. 6 (4) , 465-468
Hereditary angioedema as a cause of recurrent abdominal pain in a pediatric patient with Crohn's disease
Hereditary angioedema (HAE) is a rare genetic condition caused by deficient or dysfunctional C1 inhibitor protein (C1INH) resulting in episodic angioedema of the skin, upper airway, and gastrointestinal tract. HAE most often presents within the first two decades of life and may cause severe abdominal pain, nausea, diarrhea, and emesis, making it an important diagnosis for pediatric gastroenterologists to consider. Here, we report the case of an 11‐year‐old boy with a history of Crohn's disease who presented with recurrent episodes of acute epigastric and periumbilical pain despite evidence of endoscopic, histologic, and radiographic remission. These pain episodes lasted 12–48 h, were associated with nonbloody, nonbilious emesis, and prompted several visits to the emergency department. Abdominal exam and imaging were repeatedly unremarkable, and bloodwork was notable only for mildly elevated C‐reactive protein (<10 mg/L). Eventually, the patient presented with acute facial edema and was referred to Immunology for workup of suspected HAE. Bloodwork revealed low C4 and C1INH concentration, confirming the diagnosis of HAE type I, and the patient was started on appropriate pharmacotherapy to good effect. This case highlights the importance of investigating alternative diagnoses in patients with adequately treated inflammatory bowel disease who continue to experience gastrointestinal symptoms and exemplifies common gastrointestinal manifestations of HAE.
- 29 June 2025
- Published by Wiley in JPGN Reports
- Vol. 6 (4) , 465-468
Open AccessHereditary angioedema as a cause of recurrent abdominal pain in a pediatric patient with Crohn's disease
Hereditary angioedema (HAE) is a rare genetic condition caused by deficient or dysfunctional C1 inhibitor protein (C1INH) resulting in episodic angioedema of the skin, upper airway, and gastrointestinal tract. HAE most often presents within the first two decades of life and may cause severe abdominal pain, nausea, diarrhea, and emesis, making it an important diagnosis for pediatric gastroenterologists to consider. Here, we report the case of an 11‐year‐old boy with a history of Crohn's disease who presented with recurrent episodes of acute epigastric and periumbilical pain despite evidence of endoscopic, histologic, and radiographic remission. These pain episodes lasted 12–48 h, were associated with nonbloody, nonbilious emesis, and prompted several visits to the emergency department. Abdominal exam and imaging were repeatedly unremarkable, and bloodwork was notable only for mildly elevated C‐reactive protein (<10 mg/L). Eventually, the patient presented with acute facial edema and was referred to Immunology for workup of suspected HAE. Bloodwork revealed low C4 and C1INH concentration, confirming the diagnosis of HAE type I, and the patient was started on appropriate pharmacotherapy to good effect. This case highlights the importance of investigating alternative diagnoses in patients with adequately treated inflammatory bowel disease who continue to experience gastrointestinal symptoms and exemplifies common gastrointestinal manifestations of HAE.
- Top Cited Papers
- 15 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (93) , eadj4775
Gut bacteria–derived serotonin promotes immune tolerance in early life
The gut microbiota promotes immune system development in early life, but the interactions between the gut metabolome and immune cells in the neonatal gut remain largely undefined. Here, we demonstrate that the neonatal gut is uniquely enriched with neurotransmitters, including serotonin, and that specific gut bacteria directly produce serotonin while down-regulating monoamine oxidase A to limit serotonin breakdown. We found that serotonin directly signals to T cells to increase intracellular indole-3-acetaldehdye and inhibit mTOR activation, thereby promoting the differentiation of regulatory T cells, both ex vivo and in vivo in the neonatal intestine. Oral gavage of serotonin into neonatal mice resulted in long-term T cell–mediated antigen-specific immune tolerance toward both dietary antigens and commensal bacteria. Together, our study has uncovered an important role for specific gut bacteria to increase serotonin availability in the neonatal gut and identified a function of gut serotonin in shaping T cell response to dietary antigens and commensal bacteria to promote immune tolerance in early life.
- 15 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (93) , eadj4775
Top Cited PapersGut bacteria–derived serotonin promotes immune tolerance in early life
The gut microbiota promotes immune system development in early life, but the interactions between the gut metabolome and immune cells in the neonatal gut remain largely undefined. Here, we demonstrate that the neonatal gut is uniquely enriched with neurotransmitters, including serotonin, and that specific gut bacteria directly produce serotonin while down-regulating monoamine oxidase A to limit serotonin breakdown. We found that serotonin directly signals to T cells to increase intracellular indole-3-acetaldehdye and inhibit mTOR activation, thereby promoting the differentiation of regulatory T cells, both ex vivo and in vivo in the neonatal intestine. Oral gavage of serotonin into neonatal mice resulted in long-term T cell–mediated antigen-specific immune tolerance toward both dietary antigens and commensal bacteria. Together, our study has uncovered an important role for specific gut bacteria to increase serotonin availability in the neonatal gut and identified a function of gut serotonin in shaping T cell response to dietary antigens and commensal bacteria to promote immune tolerance in early life.
- Open Access
- 27 February 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (3) , 597
The Gut–Liver Axis in Pediatric Liver Health and Disease
There has been growing interest in the complex host–microbe interactions within the human gut and the role these interactions play in systemic health and disease. As an essential metabolic organ, the liver is intimately coupled to the intestinal microbial environment via the portal venous system. Our understanding of the gut–liver axis comes almost exclusively from studies of adults; the gut–liver axis in children, who have unique physiology and differing gut microbial communities, remains poorly understood. Here, we provide a comprehensive overview of common pediatric hepatobiliary conditions and recent studies exploring the contributions of the gut microbiota to these conditions or changes of the gut microbiota due to these conditions. We examine the current literature regarding the microbial alterations that take place in biliary atresia, pediatric non-alcoholic fatty liver disease, Wilson’s disease, cystic fibrosis, inflammatory bowel disease, and viral hepatitis. Finally, we propose potential therapeutic approaches involving modulation of the gut microbiota and the gut–liver axis to mitigate the progression of pediatric liver disease.
- 27 February 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (3) , 597
Open AccessThe Gut–Liver Axis in Pediatric Liver Health and Disease
There has been growing interest in the complex host–microbe interactions within the human gut and the role these interactions play in systemic health and disease. As an essential metabolic organ, the liver is intimately coupled to the intestinal microbial environment via the portal venous system. Our understanding of the gut–liver axis comes almost exclusively from studies of adults; the gut–liver axis in children, who have unique physiology and differing gut microbial communities, remains poorly understood. Here, we provide a comprehensive overview of common pediatric hepatobiliary conditions and recent studies exploring the contributions of the gut microbiota to these conditions or changes of the gut microbiota due to these conditions. We examine the current literature regarding the microbial alterations that take place in biliary atresia, pediatric non-alcoholic fatty liver disease, Wilson’s disease, cystic fibrosis, inflammatory bowel disease, and viral hepatitis. Finally, we propose potential therapeutic approaches involving modulation of the gut microbiota and the gut–liver axis to mitigate the progression of pediatric liver disease.
- Open Access
- 15 December 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (12) , 1996
Maternal Microbiome and Infections in Pregnancy
Pregnancy induces unique changes in maternal immune responses and metabolism. Drastic physiologic adaptations, in an intricately coordinated fashion, allow the maternal body to support the healthy growth of the fetus. The gut microbiome plays a central role in the regulation of the immune system, metabolism, and resistance to infections. Studies have reported changes in the maternal microbiome in the gut, vagina, and oral cavity during pregnancy; it remains unclear whether/how these changes might be related to maternal immune responses, metabolism, and susceptibility to infections during pregnancy. Our understanding of the concerted adaption of these different aspects of the human physiology to promote a successful pregnant remains limited. Here, we provide a comprehensive documentation and discussion of changes in the maternal microbiome in the gut, oral cavity, and vagina during pregnancy, metabolic changes and complications in the mother and newborn that may be, in part, driven by maternal gut dysbiosis, and, lastly, common infections in pregnancy. This review aims to shed light on how dysregulation of the maternal microbiome may underlie obstetrical metabolic complications and infections.
- 15 December 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (12) , 1996
Open AccessMaternal Microbiome and Infections in Pregnancy
Pregnancy induces unique changes in maternal immune responses and metabolism. Drastic physiologic adaptations, in an intricately coordinated fashion, allow the maternal body to support the healthy growth of the fetus. The gut microbiome plays a central role in the regulation of the immune system, metabolism, and resistance to infections. Studies have reported changes in the maternal microbiome in the gut, vagina, and oral cavity during pregnancy; it remains unclear whether/how these changes might be related to maternal immune responses, metabolism, and susceptibility to infections during pregnancy. Our understanding of the concerted adaption of these different aspects of the human physiology to promote a successful pregnant remains limited. Here, we provide a comprehensive documentation and discussion of changes in the maternal microbiome in the gut, oral cavity, and vagina during pregnancy, metabolic changes and complications in the mother and newborn that may be, in part, driven by maternal gut dysbiosis, and, lastly, common infections in pregnancy. This review aims to shed light on how dysregulation of the maternal microbiome may underlie obstetrical metabolic complications and infections.